Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 27, Suchdauer: 0.99s

1
Baseline immune signatures are associated with prospective COVID-19 infection and clinical outcomes in healthcare workers: Evidence from a cohort study in Brazil.

von de Gois ET ; Miranda VHS ; Jardim-Santos GP ; et al.

Immunology letters [Immunol Lett] 2026 Aug; Vol. 280, pp. 107169. Date of Electronic Publication: 2026 Mar 14.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

2
Integrated humoral and inflammatory signatures predict outcomes in severe COVID-19: a 14-day longitudinal analysis.

von Ibiapina HNS ; Magalhães-Gama F ; Neves JCF ; et al.

Clinical & translational immunology [Clin Transl Immunology] 2026 Feb 24; Vol. 15 (2), pp. e70082. Date of Electronic Publication: 2026 Feb 24 (Print Publication: 2026).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

3
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study.

von Medeiros-Junior NF ; Gouvea MDPG ; Camacho LAB ; et al.

Vaccines [Vaccines (Basel)] 2025 Oct 30; Vol. 13 (11). Date of Electronic Publication: 2025 Oct 30.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

4
Neuropsychomotor Development of Children Exposed to SARS-CoV-2 in Utero During COVID-19 Pandemic.

von Motta F ; Canellas-de-Castro ME ; Fernandes GM ; et al.

Biomedicines [Biomedicines] 2025 Sep 12; Vol. 13 (9). Date of Electronic Publication: 2025 Sep 12.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

5
Systemic and cerebrospinal fluid immune mediators coordinate a dichotomic microenvironment in parturients with acute or convalescent phases of COVID-19.

von Sasaki LMP ; Canellas-de-Castro ME ; Fernandes GM ; et al.

Immunology letters [Immunol Lett] 2025 Aug; Vol. 274, pp. 106979. Date of Electronic Publication: 2025 Feb 09.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

6
The dialog between mother and newborn: insights from immune mediator crosstalk elicited by antenatal SARS-COV-2 exposure.

von Canellas-de-Castro ME ; Sasaki LMP ; Fernandes GM ; et al.

Frontiers in immunology [Front Immunol] 2025 Jul 31; Vol. 16, pp. 1606582. Date of Electronic Publication: 2025 Jul 31 (Print Publication: 2025).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

7
Clinical characteristic and outcomes of pregnant women with COVID-19: The PROUDEST prospective cohort study.

von Sasaki LP ; Fernandes GM ; Silva ÂPD ; et al.

PloS one [PLoS One] 2025 Jul 03; Vol. 20 (7), pp. e0327174. Date of Electronic Publication: 2025 Jul 03 (Print Publication: 2025).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

8
Detection of sensory deficits in fine nerve fibres in leprosy diagnosis.

von Rodrigues Júnior IA ; Chaves AT ; de Andrade LC ; et al.

Tropical medicine & international health : TM & IH [Trop Med Int Health] 2025 Mar; Vol. 30 (3), pp. 170-180. Date of Electronic Publication: 2025 Jan 09.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

9
IL-17 as a putative hallmark of intense arthralgia and age-related serum immune mediator networks during acute chikungunya fever.

von Teixeira CW ; Dias JP ; Morgado-Santos L ; et al.

Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2025 Jan 11; Vol. 74 (1), pp. 16. Date of Electronic Publication: 2025 Jan 11.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

10
Hydroxychloroquine is associated with lower seroconversion upon 17DD-Yellow fever primovaccination in patients with primary Sjögren's syndrome.

von Libardi Lira Machado KL ; da Costa-Rocha IA ; Gonçalves Rodrigues Aguiar L ; et al.

Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2318814. Date of Electronic Publication: 2024 Jul 03.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

11
Phenotypic Timeline Kinetics, Integrative Networks, and Performance of T- and B-Cell Subsets Associated with Distinct Clinical Outcome of Severe COVID-19 Patients.

von de Oliveira G ; Costa-Rocha IA ; Oliveira-Carvalho N ; et al.

Microorganisms [Microorganisms] 2024 Nov 09; Vol. 12 (11). Date of Electronic Publication: 2024 Nov 09.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

12
MR1 blockade drives differential impact on integrative signatures based on circuits of circulating immune cells and soluble mediators in visceral leishmaniasis.

von Borges-Fernandes LO ; de Lima Moreira M ; Pereira VHS ; et al.

Frontiers in immunology [Front Immunol] 2024 Aug 13; Vol. 15, pp. 1373498. Date of Electronic Publication: 2024 Aug 13 (Print Publication: 2024).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

13
Models for predicting the risk of illness in leprosy contacts in Brazil: Leprosy prediction models in Brazilian contacts.

von de Alecrin ES ; Martins MAP ; de Oliveira ALG ; et al.

Tropical medicine & international health : TM & IH [Trop Med Int Health] 2024 Aug; Vol. 29 (8), pp. 680-696. Date of Electronic Publication: 2024 Jul 04.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

14
The seasonality as a relevant aspect to be considered for differential diagnosis of Trypanosoma vivax infection and co-infections in female cattle.

von Pandolfi IA ; de Oliveira WA ; Martins-Filho OA ; et al.

Comparative immunology, microbiology and infectious diseases [Comp Immunol Microbiol Infect Dis] 2024 Jun; Vol. 109, pp. 102180. Date of Electronic Publication: 2024 Apr 17.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

15
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.

von Reis LR ; Costa-Rocha IA ; Abdala-Torres T ; et al.

Scientific reports [Sci Rep] 2024 Apr 02; Vol. 14 (1), pp. 7709. Date of Electronic Publication: 2024 Apr 02.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

16
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.

von Abdala-Torres T ; Campi-Azevedo AC ; da Silva-Pereira RA ; et al.

NPJ vaccines [NPJ Vaccines] 2024 Mar 08; Vol. 9 (1), pp. 54. Date of Electronic Publication: 2024 Mar 08.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

17
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.

von da Penha Gomes Gouvea M ; Lira Machado KLL ; de Oliveira YGP ; et al.

Vaccine [Vaccine] 2023 Oct 20; Vol. 41 (44), pp. 6514-6528. Date of Electronic Publication: 2023 Sep 01.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

18
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.

von Fradico JRB ; Campi-Azevedo AC ; Speziali E ; et al.

Clinical immunology (Orlando, Fla.) [Clin Immunol] 2023 Jun; Vol. 251, pp. 109321. Date of Electronic Publication: 2023 Apr 03.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

19
Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study.

von Fernandes GM ; Sasaki LMP ; Jardim-Santos GP ; et al.

Frontiers in immunology [Front Immunol] 2023 Apr 12; Vol. 14, pp. 1176898. Date of Electronic Publication: 2023 Apr 12 (Print Publication: 2023).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

20
Serum Soluble Mediator Profiles and Networks During Acute Infection With Distinct DENV Serotypes.

von Coutinho-da-Silva MS ; Sucupira PHF ; Bicalho KA ; et al.

Frontiers in immunology [Front Immunol] 2022 May 31; Vol. 13, pp. 892990. Date of Electronic Publication: 2022 May 31 (Print Publication: 2022).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

21
Phenotypic and Functional Signatures of Peripheral Blood and Spleen Compartments of Cynomolgus Macaques Infected With T. cruzi: Associations With Cardiac Histopathological Characteristics.

von Sathler-Avelar R ; Vitelli-Avelar DM ; Mattoso-Barbosa AM ; et al.

Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Jul 14; Vol. 11, pp. 701930. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

22
Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.

von da Costa-Rocha IA ; Machado KLLL ; Campi-Azevedo AC ; et al.

Scientific reports [Sci Rep] 2021 May 17; Vol. 11 (1), pp. 10431. Date of Electronic Publication: 2021 May 17.
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

23
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.

von Valim V ; Machado KLLL ; Miyamoto ST ; et al.

Frontiers in immunology [Front Immunol] 2020 Jul 17; Vol. 11, pp. 1382. Date of Electronic Publication: 2020 Jul 17 (Print Publication: 2020).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

24
Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

von da Costa-Rocha IA ; Campi-Azevedo AC ; Peruhype-Magalhães V ; et al.

Frontiers in immunology [Front Immunol] 2019 Oct 22; Vol. 10, pp. 2433. Date of Electronic Publication: 2019 Oct 22 (Print Publication: 2019).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

25
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.

von Campi-Azevedo AC ; Reis LR ; Peruhype-Magalhães V ; et al.

Frontiers in immunology [Front Immunol] 2019 Sep 26; Vol. 10, pp. 2192. Date of Electronic Publication: 2019 Sep 26 (Print Publication: 2019).
- View full text via DOI
- Zur Referenz in PubMed
Merkliste

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag